Traws Pharma, Inc. (TRAW)
NASDAQ: TRAW · Real-Time Price · USD
1.420
-0.050 (-3.40%)
At close: Jun 2, 2026, 4:00 PM EDT
1.420
0.00 (0.00%)
Pre-market: Jun 3, 2026, 5:59 AM EDT
Traws Pharma Stock Forecast
Stock Price Forecast
The 2 analysts that cover Traws Pharma stock have a consensus rating of "Buy" and an average price target of $7.25, which forecasts a 410.56% increase in the stock price over the next year. The lowest target is $6.50 and the highest is $8.00.
Price Target: $7.25 (+410.56%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Traws Pharma stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 2 | 2 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 2 | 2 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $8 | Buy | Reiterates | $8 | +463.38% | May 21, 2026 |
| Ladenburg Thalmann & Co. | Ladenburg Thalmann & Co. | Buy Initiates $6.5 | Buy | Initiates | $6.5 | +357.75% | Jan 30, 2026 |
Financial Forecast
Revenue This Year
n/a
from 2.79M
Revenue Next Year
13.36M
EPS This Year
-2.56
from 0.83
EPS Next Year
-2.47
from -2.56
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | n/a | 27.5M | ||||||
| Avg | n/a | 13.4M | ||||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -2.42 | -1.35 | |
| Avg | -2.56 | -2.47 | |
| Low | -2.66 | -3.49 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and consensus ratings provided by TipRanks. Historical ratings and analyst data provided by TipRanks. Financial forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.